CCMU
ORGS

Cheyne Capital Management (UK)’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Cheyne Capital Management (UK)’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,900
Closed -$208K – 46
2019
Q1 		$208K Hold
3,900
– – 0.19% 34
2018
Q4 		$183K Buy
+3,900
New +$224K 0.17% 34

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCM
Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return
DG
Delek Group Herzliya, Israel $2.59B AUM 1.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.25B AUM 19.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TFGT
TS Financial Group (TSFG) Lake Forest, Illinois $794M AUM 24.65% 1-Year Est. Return

Cheyne Capital Management (UK)'s ORGS Position: Q2 2019 in Review

Cheyne Capital Management (UK) sold out of Orgenesis Inc. Common Stock (ORGS) in Q2 2019, closing a stake of 3,900 shares — an estimated $208K sold.

Cheyne Capital Management (UK) first reported a position in ORGS in Q4 2018 and held it in 2 quarters. The position peaked at $208K in Q1 2019. 16 funds tracked by Wall St. Rank hold ORGS as of Q2 2019.

  • Cheyne Capital Management (UK) reported no remaining Orgenesis Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Cheyne Capital Management (UK) sold 3,900 Orgenesis Inc. Common Stock shares in Q2 2019, an estimated $208K.
  • Cheyne Capital Management (UK) first reported a position in Orgenesis Inc. Common Stock in Q4 2018 and held it in 2 quarters.
  • Cheyne Capital Management (UK)'s Orgenesis Inc. Common Stock position peaked at $208K in Q1 2019.
  • 16 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q2 2019.

Based on Cheyne Capital Management (UK)'s 13F filing for Q2 2019, filed 8 Aug 2019.